Equity Offerings

• BofA Securities, Piper Sandler, J.P. Morgan and Goldman Sachs & Co. LLC as representatives of the underwriters in connection with the upsized follow-on offering by Kestra Medical Technologies, Ltd. of 6,900,000 shares of common stock at a public offering price of USD23.00 per share, resulting in gross proceeds of approximately USD158.7m.
  
• Santander as sole book-running manager on the upsized initial public offering of SilverBox Corp V, a special-purpose acquisition company, of 37,600,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of USD276m.
• BofA Securities, Evercore ISI, and Goldman Sachs & Co. LLC, as representatives of the underwriters in connection with the follow-on public offering by Mineralys Therapeutics, Inc. of 9,803,921 shares of its common stock at a public offering price of USD25.50 per share, resulting in aggregate gross proceeds to Mineralys Therapeutics, Inc. of approximately USD250m, as well as their full exercise of an option to purchase 1,470,588 shares of common stock at a public offering price of USD25.50 per share, resulting in gross proceeds to the Company of approximately USD37.5m.
  
• BofA Securities as placement agent in connection with the private placement by InspireMD, Inc. of 6,791,380 shares of its common stock and pre-funded warrants to purchase 9,764,804 shares of common stock, resulting in aggregate gross proceeds to InspireMD, Inc. of approximately USD40.1m.
  
• TD Cowen as sales agent in connection with the commencement of Allbirds, Inc.’s at-the-market equity offering program to sell its common stock having an aggregate offering price of up to USD22.5m.
• BofA Securities, Evercore ISI, and Goldman Sachs & Co. LLC, as representatives of the underwriters in connection with the follow-on public offering by Mineralys Therapeutics, Inc. of 12,962,962 shares of its common stock at a public offering price of USD13.50 per share, resulting in aggregate gross proceeds to Mineralys Therapeutics, Inc. of approximately USD175m.
• BofA Securities, Goldman Sachs & Co. LLC and Piper Sandler as lead bookrunners, Wells Fargo Securities and Stifel as bookrunners, and Wolfe | Nomura Alliance as co-manager in connection with the upsized initial public offering of 11,882,352 shares of common stock of Kestra Medical Technologies, Ltd. at a public offering price of USD17.00 per share, resulting in gross proceeds to the company of USD202m.
• TD Securities and Goldman Sachs as underwriters in connection with a USD13.1bn secondary registered offering of shares of The Charles Schwab Corporation by The Toronto-Dominion Bank. The transaction marked the largest financial services public equity offering of the past five years and one of the largest equity offerings in the United States in a decade. Through the equity offering and a USD1.5bn repurchase by Charles Schwab of its shares from TD Bank, TD Bank sold its entire 10.1% economic stake in Charles Schwab for a total of USD14.6bn in gross proceeds.
• BofA Securities and J.P. Morgan as joint book-running managers and William Blair, TD Cowen and Canaccord Genuity as co-managers in connection with the upsized initial public offering of 10,606,060 shares of common stock of CeriBell, Inc. at a public offering price of USD17.00 per share, resulting in gross proceeds to the company of USD207m.
• BofA Securities and J.P. Morgan as joint underwriters and bookrunning managers in connection with the follow-on public offering by Bruker Corporation of 6,000,000 shares of its common stock at a public offering price of USD67.29 per share, resulting in aggregate gross proceeds to Bruker Corporation of approximately USD403.7m.
• BofA Securities and Evercore as placement agents in connection with the private placement by Mineralys Therapeutics, Inc. of 8,339,169 shares of its common stock and pre-funded warrants to purchase 549,755 shares of common stock, resulting in aggregate gross proceeds to Mineralys of approximately USD120m.
• Deutsche Bank AG, as the PIPE placement agent to Lotus Technology Inc. (Lotus Tech), and Santander US Capital Markets LLC, as the capital markets advisor to L Catterton Asia Acquisition Corp. (LCAA), in connection with the business combination between Lotus Tech and LCAA. The business combination values Lotus Tech at USD5.5bn on a pre-money equity value basis.
• BofA Securities as placement agent in connection with the commencement of iRobot Corporation’s at-the-market equity program to sell shares of its common stock, no par value, having an aggregate offering price of up to USD100m.
• Evercore ISI as sales agent in connection with the commencement of Quantum-Si Incorporated’s at-the-market equity program to sell shares of common stock, having an aggregate offering price of up to USD75m.
• Morgan Stanley & Co. LLC and Cowen and Company, LLC as joint book-running managers in connection with the follow-on public offering by Vicarious Surgical Inc. of 45,000,000 shares of its common stock at a public offering price of USD1.00 per share, resulting in aggregate gross proceeds to Vicarious Surgical Inc. of approximately USD45m.
• BofA Securities, TD Cowen and Piper Sandler as joint book-running managers in connection with the follow-on public offering by PROCEPT BioRobotics® Corporation of 4,422,169 shares of its common stock at a public offering price of USD33.92 per share, resulting in aggregate gross proceeds to by PROCEPT BioRobotics® Corporation of approximately USD150m.
• BofA Securities, Leerink Partners, Evercore ISI and RBC Capital Markets as joint book-running managers in connection with the follow-on public offering by Caribou Biosciences, Inc. of 22,115,384 shares of its common stock at a public offering price of USD6.50 per share, resulting in aggregate gross proceeds to Caribou Biosciences, Inc. of approximately USD143.75m.
• BofA Securities, TD Cowen and Piper Sandler as joint book-running managers in connection with the follow-on public offering by Inozyme Pharma, Inc. of 14,375,000 shares of its common stock at a public offering price of USD4.80 per share, resulting in aggregate gross proceeds to Inozyme Pharma, Inc. of approximately USD64.5m.
• BofA Securities and ThinkEquity LLC as placement agents in connection with the commencement of Annovis Bio, Inc.’s at-the-market equity program to sell shares of common stock.
• Worldwide Webb Acquisition Corp in connection with its acquisition of Aeries Technology.
• Cowen and Company, LLC as placement agent in connection with the commencement of Homology Medicines Inc.’s at-the-market equity program to sell shares of common stock.
• BofA Securities as financial advisor in connection with the PIPE investment of HPX Corp. and its acquisition of Ambipar Emergency Response
  Credit Suisse, BofA Securities, SVB Securities and Van Lanschot Kempen as placement agents in connection with the USD91m PIPE investment of European Biotech Acquisition Corp. and its acquisition of Oculis SA.
• Credit Suisse as sole book-running manager on the upsized initial public offering of SilverBox Corp III, a special purpose acquisition company, of 13,800,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD139.38m.
• BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse and Wells Fargo Securities acted as joint book-running managers in connection with the upsized initial public offering of 13,800,000 shares of common stock of Mineralys Therapeutics, Inc. at a public offering price of USD16.00 per share, resulting in gross proceeds to the company of USD220.8m.
• BofA Securities, Piper Sandler, Canaccord Genuity, JMP Securities, a Citizens Company, and Needham & Company as underwriters in connection with the follow-on public offering of 6,500,000 shares of common stock of Paragon 28, Inc. at a public offering price of USD17.00 per share, resulting in gross proceeds to the company of approximately USD103.4m.
• Morgan Stanley as the sole book-running manager in connection with the follow-on public offering of 3,987,914 shares of common stock of Tidewater Inc. at a public offering price of USD30.25 per share, resulting in gross proceeds to the company of approximately USD120.6m.
• Citigroup Global Markets Inc. and Guggenheim Securities, LLC as underwriters in connection with Spring Valley Acquisition Corp. II’s initial public offering of 23,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD230m.
• BofA Securities, Stifel and Nicolaus & Company, Incorporated as co-lead placement agents in connection with the private placement offering of 23,045,536 shares of its common stock by Sonendo, Inc. at a purchase price of USD0.95 per share, resulting in gross proceeds to the company of approximately USD63m.
• BofA Securities as the sole placement agent in connection with the private placement offering by 5E Advanced Materials of USD60m aggregate principal amount of its 4.50% secured convertible notes to BEP Special Situations IV.
• BofA Securities as the sole book-running manager in connection with the follow-on public offering of 2,012,500 shares of common stock of Axonics, Inc. at a public offering price of USD63.85 per share, resulting in gross proceeds to the company of approximately USD128.5m.
• Goldman Sachs & Co. LLC as the sole book-running manager in connection with the follow-on public offering of 1,150,000 shares of common stock of Inspire Medical Systems, Inc. at a public offering price of USD215.00 per share, resulting in gross proceeds to the company of approximately USD247.2m.
• Morgan Stanley as the sole book-running manager in connection with the follow-on public offering of 4,048,000 shares of common stock of Tidewater Inc. at a public offering price of USD17.85 per share, resulting in gross proceeds to the company of approximately USD72.3m.
• BofA Securities, Jefferies, Barclays, Raymond James and LifeSci Capital as joint book-running managers in connection with the follow-on public offering by Tarsus Pharmaceutical Inc. of 5,600,000 shares of its common stock at a public offering price of USD13.50 per share, resulting in aggregate gross proceeds to Tarsus Pharmaceutical Inc. of approximately USD75.6m.
• Morgan Stanley, Baird, Blaylock Van, LLC, Wells Fargo Securities, Janney Montgomery Scott and Ramirez & Co., Inc. as placement agents in connection with the commencement of California Water Service Group’s at-the-market equity program to sell shares of its common stock, having an aggregate offering price of up to USD350m.
• BofA Securities and Morgan Stanley as joint book-running managers and Wells Fargo Securities, Canaccord Genuity and BTIG as co-managers in connection with the follow-on public offering by Inari Medical, Inc. of 2,000,000 shares of common stock at a public offering price of USD81 per share, resulting in gross proceeds to Inari of approximately USD162m.
• Citigroup Global Markets Inc. as underwriter in connection with Athena Technology Acquisition Corp. II’s initial public offering of 25,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD250m.
• BofA Securities as underwriter in connection with APx Acquisition Corp. I’s initial public offering of 17,250,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD172.5m.
• Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc., Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc. as placement agents in connection with the USD154m PIPE investment of Oaktree Acquisition Corp. II and its related acquisition of Alvotech Lux Holdings S.A.S.
• Cowen and Company, LLC as placement agent in connection with the commencement of Orphazyme A/S’s at-the-market equity program to sell shares of its common stock.
• Worldwide Webb Acquisition Corp. in connection with its initial public offering of 23,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD230m.
• BofA Securities and Piper Sandler as underwriters in connection with Paragon 28, Inc.’s initial public offering of 8,984,375 shares of common stock at a public offering price of USD16.00 per share, resulting in gross proceeds to the company of USD144m.
• Citigroup Global Markets Inc. as underwriter in connection with Athena Consumer Acquisition Corp.’s initial public offering of 23,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD230m.
• BofA Securities, Goldman Sachs & Co. LLC, Piper Sandler and Stifel as book-running managers in connection with Sonendo’s initial public offering of 7,800,000 shares of common stock at a public offering price of USD12.00 per share, resulting in gross proceeds to the company of USD93.6m.
• Evercore ISI as the sole book-running manager on the initial public offering of Learn CW Investment Corp., a special purpose acquisition company, of 23,000,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD230m.
• BofA Securities and J.P. Morgan Securities as placement agents on a USD300m PIPE transaction in connection with the de-SPAC combination between TWC Tech Holdings and Cellebrite, a digital intelligence solution company.
• Morgan Stanley, Goldman Sachs & Co. LLC, Piper Sandler and Cowen as underwriters in connection with Cytek Biosciences, Inc.’s initial public offering of 16,749,330 shares of common stock at a public offering price of USD17.00 per share, resulting in gross proceeds to the company of approximately USD237m.
• BofA Securities, Citigroup and SVB Leerink as underwriters in connection with Caribou Biosciences, Inc.’s initial public offering of 19,000,000 shares of common stock at a public offering price of USD16.00 per share, resulting in gross proceeds to the company of approximately USD304m.
• BofA Securities and Citigroup Global Markets Inc. as co-placement agents on a USD2.5bn PIPE transaction in connection with the de-SPAC combination between SPAC Churchill Capital Corp. IV and Lucid Motors, Inc., an electric car manufacturer.
• J.P. Morgan, Piper Sandler and William Blair as underwriters in connection with CVRx, Inc.’s offering of 7,000,000 shares of common stock at a public offering price of USD18.00 per share, resulting in gross proceeds to the company of approximately USD126m.
• Credit Suisse, Citigroup, UBS Investment Bank, BTIG, Guggenheim Securities and Macquarie Capital as joint book-running managers on the initial public offering of Elliott Opportunity II, a special purpose acquisition company, of 60,950,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD609.5m.
• BofA Securities, Piper Sandler, SVB Leerink, Baird, Guggenheim Securities, Needham & Company and Truist Securities as underwriters in connection with Axonics, Inc.’s offering of 3,500,000 shares of common stock at a public offering price of USD50.00 per share, resulting in gross proceeds to the company of approximately USD175m.
• BofA Securities and Barclays as joint book-running managers on the initial public offering of Valor Latitude Acquisition Corp, a special purpose acquisition company, of 20,000,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD200m.
• Citigroup Global Markets Inc. as underwriter on the initial public offering of two, a special purpose acquisition company, of 20,000,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD200m.
• Morgan Stanley, Cantor and Guggenheim Securities as underwriters on the initial public offering of Forest Road Acquisition Corp. II, a special purpose acquisition company, of 30,500,000 units at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to the company of USD350m.
• Barclays and BTIG as placement agents in connection with a private investment in 10,000,000 shares of Colonnade Acquisition Corp., a special purpose acquisition company, immediately prior to Colonnade’s acquisition of Ouster, Inc., resulting in gross proceeds to the company of USD1.8bn.
• J.P. Morgan, Morgan Stanley and BofA Securities as joint book-running managers and H.C. Wainwright & Co. and Kempen & Co. as lead co-managers in connection with the follow-on public offering by Y-mAbs Therapeutics, Inc. of 2,804,878 shares of common stock at a public offering price of USD41 per share, resulting in aggregate gross proceeds to Y-mAbs of approximately USD115m.
• Cowen and Intrepid Partners as joint book-running managers in connection with the initial public offering of Flame Acquisition Corp., a special purpose acquisition company, of 28,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD287m.
• Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. as underwriters in connection with the initial public offering of SilverBox Engaged Merger Corp I, a special purpose acquisition company, of 34,500,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD345m.
• Citigroup Inc. and BofA Securities as initial purchasers in connection with the initial public offering of Alpha Capital Acquisition Company, a special purpose acquisition company, of 23,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD230m.
• Citigroup as the sole book-running manager in connection with the initial public offering of Arctos NorthStar Acquisition Corp., a special purpose acquisition company, of 31,625,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD316m.
• Citigroup and Jefferies as joint book-running managers in connection with the initial public offering of New Vista Acquisition Corp, a special purpose acquisition company, of 27,600,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD276m.
• Bank of America Securities as the book-running manager and Oppenheimer & Co. as the co-manager in connection with the follow-on public offering by Protalix BioTherapeutics’ (Protalix) of 8,750,000 shares of common stock at a public offering price of USD4.60 per share, resulting in aggregate gross proceeds to Protalix of approximately USD40.2m.
• BofA Securities and William Blair as joint lead book-running managers and LifeSci Capital as co-manager in connection with Lucira Health, Inc.’s initial public offering of 10,350,000 shares of common stock at a public offering price of USD17.00 per share, resulting in gross proceeds to the company of approximately USD176m.
• Cowen and Company, LLC and Wells Fargo Securities, LLC as book-running managers and Drexel Hamilton, LLC and Siebert Williams Shank & Co., LLC as co-managers in connection with the initial public offering of Spring Valley Acquisition Corp., a special purpose acquisition company, of 23,000,000 units at an offering price of USD10.00 per unit, resulting in gross proceeds to the company of USD230m.
• BofA Securities, Jefferies and Raymond James as joint lead book-running managers and LifeSci Capital and Ladenburg Thalmann as co-managers in connection with Tarsus Pharmaceuticals’ initial public offering of 6,325,000 shares of common stock at a public offering price of USD16.00 per share, resulting in gross proceeds to the company of approximately USD101.2m.
• BofA Securities as sole bookrunning manager in connection with the initial public offering of 5:01 Acquisition Corp., 5AM Ventures’ biotech SPAC, offering 8,000,000 shares of Class A common stock at USD10.00 per share, resulting in gross proceeds to the Company of USD80m.
• BofA Securities and Morgan Stanley as joint lead book-running managers in connection with Pulmonx Corporation’s initial public offering of 11,500,000 shares of common stock at a public offering price of USD19.00 per share, resulting in gross proceeds to the Company of approximately USD218.5m.
• BofA Securities, Cowen and Guggenheim Securities as the joint book-running managers in connection with the global offering of Orphazyme A/S, consisting of 3,966,146 American depositary shares in its initial public offering in the U.S. and 3,650,000 ordinary shares in a European private placement, resulting in gross proceeds to Orphazyme of approximately USD83.8m.
• BofA Securities as sales agent in connection with the commencement of Protalix BioTherapeutics, Inc.’s at-the-market equity program to sell shares of its common stock, having an aggregate offering price of up to USD30m.
• BofA Securities, China Renaissance Securities (Hong Kong) Limited, ICBC International Securities Limited and A.G.P./Alliance Global Partners, as joint book-runners, in connection with the SEC-registered follow-on offering of 8,500,001 American Depositary Shares representing 4,250,000.5 Class A ordinary shares of iClick Interactive Asia Group Limited for a total consideration of USD72.25m.
• BofA Securities and Jefferies LLC in connection with the commencement of Lithia Motors, Inc.’s at-the-market equity program to sell shares of its common stock, no par value, having an aggregate offering price of up to USD400m.
• Cowen, Evercore ISI, Stifel and Mizuho Securities as joint book-running managers in connection with Nkarta, Inc.’s initial public offering of 16,100,000 shares of common stock at a public offering price of USD18.00 per share, resulting in gross proceeds to Nkarta of approximately USD289.8m.
• BofA Securities, ICBC International Securities Limited and A.G.P./Alliance Global Partners, as placement agents, in connection with the private placement offering by iClick Interactive Asia Group Limited of 2,107,400 Class A ordinary shares for a total consideration of USD22m.
• BofA Securities and Morgan Stanley as joint book-running managers in connection with Inari Medical, Inc.’s initial public offering of 9,432,949 shares of common stock at a public offering price of USD19.00 per share, resulting in gross proceeds to the Company of approximately USD179.2m.
• Morgan Stanley and BofA Securities as joint book-running managers in connection with the follow-on public offering by MGE Energy of 1,495,000 shares of its common stock at a public offering price of USD56.00 per share, resulting in aggregate gross proceeds to MGE Energy of approximately USD80.2m.
• BofA Securities, Jefferies and William Blair as joint book-running managers and representatives of the underwriters in connection with Lyra Therapeutics, Inc.’s initial public offering of 4,025,000 shares of common stock (including 525,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of USD16.00 per share, resulting in gross proceeds to the company of USD64.4m.
• BofA Securities, J.P. Morgan Securities and Goldman Sachs & Co. LLC as joint book-running managers and representatives of the underwriters in connection with Inspire Medical Systems, Inc.’s offering of 2,300,000 shares common stock (including 300,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of USD58.00 per share, resulting in gross proceeds to the company of approximately USD133m.
• BofA Securities as sole book-running manager in connection with Exact Sciences’ public offering of USD1.15bn aggregate principal amount of its 0.3750% convertible senior notes due 2028, including USD150m in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised over-allotment option.
• BofA Securities, Citigroup and Credit Suisse as joint book-running managers and representatives of the underwriters in connection with Galera Therapeutics, Inc.’s initial public offering of 5,000,000 million shares of common stock at a public offering price of USD12.00 per share, resulting in gross proceeds to Galera of approximately USD60m.
• Morgan Stanley, J.P. Morgan and Evercore ISI as representatives of the underwriters in connection with pdvWireless, Inc.’s (dba Anterix) follow-on primary public offering of 2,222,223 shares of common stock at a public offering price of USD45.00 per share, resulting in approximately USD100m in gross proceeds to Anterix.
• Citigroup, Barclays, BofA Securities and Guggenheim Securities, as joint book-running managers and representatives of the underwriters in connection with a follow-on public offering by InterXion Holding N.V. of 4,600,000 ordinary shares at a public offering price of USD72.75 per share, resulting in aggregate gross proceeds to InterXion of approximately USD321m.
• Jefferies LLC as sole book-running manager on the initial public offering of Landcadia Holdings II, Inc. of 31,625,000 units, which includes 4,125,000 units issued pursuant to the exercise by Jefferies of its over-allotment option in full, at an offering price of USD10.00 per unit, resulting in aggregate gross proceeds to Landcadia Holdings II, Inc. of approximately USD316.25m.
• Credit Suisse and BofA Securities as joint book-running managers in connection with the USD250m initial public offering of Crescent Acquisition Corp of 25,000,000 units at an offering price of USD10.00 per unit, each unit consisting of one share of Class A common stock and one-half of one redeemable warrant.
• BofA Securities, SVB Leerink and RBC Capital Markets as joint book-running managers and representatives of the underwriters in connection with HOOKIPA Pharma Inc.’s initial public offering of 6,000,000 shares of common stock at a public offering price of USD14.00 per share, resulting in gross proceeds to the company of approximately USD84m.
• BofA Securities and Cowen as joint book-running managers and representatives of the underwriters in connection with Homology Medicines’ follow-on offering, resulting in gross proceeds to the company of approximately USD125m.
• BofA Securities and the other underwriters in Exact Sciences Corporation’s (i) public offering of USD747.5m aggregate principal amount of its 0.3750% convertible senior notes due 2027, including USD97.5m in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised over-allotment option and (ii) concurrent exchange of approximately USD493.4m of its outstanding principal amount of 1.0% convertible senior notes due 2025 for consideration consisting of an aggregate amount of approximately USD493.3m in cash and an aggregate amount of approximately 2,160,000 shares of the company’s common stock.
• Cantor Fitzgerald as the sole book-running manager in connection with the follow-on primary public offering of common stock of Globalstar, Inc., resulting in gross proceeds to the company of approximately USD60m.
• BofA Securities, Leerink Partners and Wells Fargo Securities as joint book-running managers and Guggenheim Securities and Stifel as lead managers in connection with Inspire Medical Systems, Inc.’s follow-on primary and secondary public offering of 2,875,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 375,000 additional shares, at a public offering price of USD40.00 per share, resulting in combined gross proceeds to Inspire and the selling stockholders of approximately USD115m.
• BofA Securities and Morgan Stanley as joint book-running managers and representatives of the underwriters in connection with Axonics Modulation Technologies, Inc.’s initial public offering of 9,200,000 shares of common stock (including 1,200,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of USD15.00 per share, resulting in gross proceeds to the company of approximately USD138m.
• BofA Securities and Cowen and Company, LLC as joint book-running managers and representatives of the underwriters in connection with Y-mAbs Therapeutics, Inc.’s initial public offering of 6,900,000 shares of common stock (including 900,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of USD16.00 per share, resulting in gross proceeds to the Company of approximately USD98.3m.
• BofA Securities as the sole book-running manager and representative of the underwriters in connection with a follow-on public offering of 6,325,000 shares of Class A common stock of Tilly’s, Inc. (including 825,000 shares purchased by underwriters pursuant to their option to purchase additional shares) sold by certain of its stockholders, including its co-founders Mr. Hezy Shaked and Ms. Tilly Levine.
• Wells Fargo Securities and Piper Jaffray & Co. as joint book-runners and representatives of the underwriters in connection with Merit Medical Systems, Inc.’s follow-on primary public offering of 4,025,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 525,000 additional shares, at a public offering price of USD54.00 per share, resulting in approximately USD204.9m in net proceeds.
• BofA Securities and Goldman Sachs & Co. LLC as joint book-running managers and representatives of the underwriters in connection with Inspire Medical Systems Inc.’s initial public offering, resulting in gross proceeds to the company of approximately USD124.2m.
• BofA Securities, Cowen and Evercore ISI as joint book-running managers and representatives of the underwriters in connection with Homology Medicines’ initial public offering, resulting in gross proceeds to the company of approximately USD165.6m.
• BofA Securities as the sole book-running manager and representative of the underwriters in connection with Exact Sciences Corporation’s public offering of USD690m 1% convertible senior notes due 2025 (including USD90m of notes purchased by the underwriters pursuant to their fully exercised over-allotment option) with an initial conversion price of approximately USD75.43 per share of common stock.
• Morgan Stanley, as representative of the underwriters in connection with Globalstar, Inc.’s follow-on public offering of common stock, resulting in gross proceeds of USD119m.
• Credit Suisse, as representative of the underwriters in connection with Social Capital Hedosophia Holdings Corp.’s initial public offering, resulting in gross proceeds of USD600m.
• Citigroup, Goldman Sachs, BofA Securities and J.P. Morgan as representatives of the underwriters in connection with the initial public offering of Venator Material PLC, a subsidiary of Huntsman Corporation, resulting in gross proceeds of USD522.1m.
• BofA Securities and Piper Jaffray as representatives of the underwriters in connection with Merit Medical Systems, Inc.’s follow-on primary public offering of 5,175,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 675,000 additional shares, resulting in gross proceeds of USD136.5m.
• BofA Securities and Piper Jaffray as representatives of the underwriters in connection with the follow-on public offering of 4,059,500 shares of common stock of Entellus Medical, Inc. consisting of 2,883,030 shares sold by Entellus and 1,176,470 shares sold by certain of its stockholders.
• BofA Securities, Citigroup and Morgan Stanley as representatives of the underwriters in connection with Valvoline Inc.’s initial public offering, resulting in gross proceeds of USD759m.
• BofA Securities and Piper Jaffray as representatives of the underwriters in connection with the initial public offering of Entellus Medical, Inc. on The Nasdaq Global Market.
• Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman, Sachs & Co. as representatives of the underwriters in connection with the initial public offering of Zayo Group Holdings, Inc. on the New York Stock Exchange.
• Goldman, Sachs & Co, Barclays Capital Inc. and Morgan Stanley & Co. LLC as representatives of the underwriters in connection with the follow-on offering of common stock by Zayo Group Holdings, Inc.
• Synchronoss Technologies, Inc. in connection with a registered offering of convertible senior notes.
• Morgan Stanley, J.P. Morgan, Goldman, Sachs & Co. and Deutsche Bank Securities in connection with a USD595m registered secondary offering of common stock by certain selling stockholders of Tribune Media Company.
• Merrill Lynch & Co. and Goldman, Sachs & Co. as representatives of the underwriters in connection with a common stock and convertible notes offering by Western Refining, Inc.
• HeartWare International, Inc. in connection with a follow-on registered public offering of common stock.
• The underwriters in connection with the initial public offering of Alnylam Pharmaceuticals, Inc. and a follow-on common stock offering.
• The underwriters in connection with several common stock offerings by Orient-Express Hotels Ltd.
• The underwriters in connection with a common stock offering by Sea Containers Ltd.
• The underwriters in connection with a common stock offering by McCormick & Schmick’s Seafood Restaurants, Inc.
• American Axle & Manufacturing Holdings, Inc. (AAM) in connection with its issuance of equity warrants to General Motors Company as part of AAM’s debt restructuring.
• Lincoln Educational Services Corporation in connection with its initial public offering and several common stock offerings.
• Stonington Partners Inc. in connection with several registered and unregistered sales of common stock of Lincoln Educational Services Corporation.

High Yield Debt Offerings

• Valvoline Inc. on the refinancing of existing debt in connection with the sale of its Global Products business to Aramco for USD2.65bn.
• Valvoline Inc. on its Rule 144A/Regulation S offering of USD535m senior notes.
• Valvoline Inc. on its Rule 144A/Regulation S offering of USD400m senior notes.
• Morgan Stanley & Co. LLC, Barclays Capital Inc., SunTrust Robinson Humphrey, Inc., RBC Capital Markets, LLC, Citigroup Global Markets Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC as joint lead and joint book-running managers in connection with the offering of USD800m senior notes by Zayo Group, LLC and Zayo Capital, Inc.
• Citigroup Global Markets Inc., as representative of the initial purchasers, in connection with the offering of USD375m senior notes by Valvoline Finco Two LLC.
• The initial purchasers in connection with one of the largest leveraged buyouts, which included the issuances of over USD11bn of high yield notes by TXU Corp. (now known as Energy Future Holdings) and its subsidiary Texas Competitive Electric Holdings Company LLC to fund the USD45bn acquisition of TXU Corp. by an investor group led by KKR and TPG.
• The initial purchasers in connection with various issuances of high yield notes by Cablevision Systems Corporation and its subsidiary CSC Holdings, Inc.
• The initial purchasers in connection with several issuances of high yield notes in excess of USD1bn by Zayo Group, LLC.
• B/E Aerospace, Inc. in connection with its USD1.05bn acquisition of Honeywell’s Consumables Solutions distribution business and the related issuance of USD600m of high yield notes.
• The initial purchasers in connection with the issuance of USD600m of secured high yield notes by Western Refining, Inc.
• The initial purchaser in connection with the issuance of USD105m of high yield notes by Da-Lite Screen Company, Inc.

Investment Grade Debt Offerings

• The underwriters in connection with the offering by CBOE Holdings, Inc. of USD300m senior notes.
• The underwriters in connection with the issuance of USD5bn of notes by Time Warner Cable Inc.
• The underwriters in connection with several issuances in excess of USD4bn of notes by The Boeing Company and Boeing Capital Corporation.
• Dr. Pepper Snapple Group, Inc. in connection with its issuance of USD1.5bn of notes.
• Boston Scientific Corporation in connection with its issuance of USD2bn of notes.
• The underwriters in connection with the issuance of USD1.5bn of notes by Life Technologies Corporation.
• The underwriters in connection with the issuance of USD500m of notes by Thomson Reuters Corporation.
• The underwriters in connection with the issuance of USD500m of notes by The Lubrizol Corporation.

Tender Offers and Consent Solicitations

• Valvoline Inc. in connection with a debt tender offer to repurchase up to USD1.0bn in value of its common stock.
• DaimlerChrysler AG in connection with a tender offer, consent solicitation and exchanges of trust securities into debentures in connection with its sale of an 80.1% interest in Chrysler Holding LLC to Cerberus Capital Management, L.P.
• The dealer managers in connection with tender offers by Cablevision Systems Corporation and its subsidiary CSC Holdings, Inc.